VIR
HealthcareVir Biotechnology, Inc.
$9.23-0.26 (-2.69%)
Prev Close
$9.48
Open
$9.47
High
$9.48
Low
$8.98
Volume
1.75M
Market Cap
$1.37B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Vir Biotechnology, Inc. (VIR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 32 insider sales totaling $20.60M. The most recent insider transaction was by SATO VICKI L (director), who sold $209.2K worth of shares on Mar 3, 2026. Vir Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.37B.
Buys (12M)
0
$0.00
Sells (12M)
32
$20.60M
Net Activity
Net Seller
$20.60M
Active Insiders
8
last 12 mo
VIR Price Chart
VIR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $9.51 | $209.2K | 1,122,590 |
| Feb 26, 2026↗ | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 14,762 | $9.53 | $140.7K | 1,020,700 |
| Feb 26, 2026↗ | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 3,505 | $9.69 | $34.0K | 155,913 |
| Feb 26, 2026↗ | SATO VICKI L | director | Sell | 42,377 | $9.75 | $413.4K | 1,144,590 |
| Feb 24, 2026↗ | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 38,078 | $7.45 | $283.8K | 1,035,470 |
| Feb 24, 2026↗ | de Verneuil Vanina | General Counsel | Sell | 4,445 | $7.45 | $33.1K | 129,799 |
| Feb 24, 2026↗ | Eisner Mark | VP | Sell | 4,178 | $7.45 | $31.1K | 157,529 |
| Feb 24, 2026↗ | O'Byrne Jason | CFO | Sell | 2,089 | $7.45 | $15.6K | 164,249 |
| Feb 24, 2026↗ | Sabatini Brent | Principal Accounting Officer | Sell | 1,829 | $7.45 | $13.6K | 71,043 |
| Feb 18, 2026↗ | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 1,530 | $7.79 | $11.9K | 0 |
| Feb 3, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $7.71 | $169.7K | 1,144,390 |
| Jan 5, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $5.93 | $130.4K | 1,166,390 |
| Dec 3, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 191,854 | $5.98 | $1.15M | 13,728,900 |
| Dec 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $6.00 | $132.1K | 1,188,390 |
| Dec 1, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 189,431 | $6.41 | $1.21M | 13,982,300 |
| Nov 26, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 463,774 | $6.27 | $2.91M | 14,346,200 |
| Nov 4, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.64 | $124.0K | 1,210,390 |
| Oct 30, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 24,553 | $6.50 | $159.7K | 14,574,100 |
| Oct 28, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 113,099 | $6.01 | $679.9K | 14,664,900 |
| Oct 24, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 298,649 | $6.07 | $1.81M | 14,866,000 |
| Oct 22, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 330,210 | $6.23 | $2.06M | 15,120,000 |
| Oct 17, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 29,515 | $6.08 | $179.6K | 15,353,300 |
| Oct 14, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 251,360 | $6.14 | $1.54M | 15,372,300 |
| Oct 9, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 538,375 | $5.99 | $3.22M | 16,087,600 |
| Oct 7, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 524,297 | $5.57 | $2.92M | 16,233,700 |
| Oct 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.84 | $128.4K | 1,232,390 |
| Sep 3, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.8K | 1,254,390 |
| Aug 4, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.7K | 1,276,390 |
| Jul 17, 2025↗ | Eisner Mark | EVP and Chief Medical Officer | Sell | 10,382 | $5.47 | $56.8K | 108,204 |
| Jul 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.10 | $112.2K | 1,298,390 |
| Jun 2, 2025↗ | Napolitano Janet | Director | Sell | 3,200 | $5.05 | $16.1K | 16,416 |
| Apr 4, 2025↗ | De Backer Marianne | Chief Executive Officer | Sell | 79,712 | $5.95 | $474.2K | 769,505 |
| Feb 25, 2025↗ | De Backer Marianne | Chief Executive Officer | Sell | 16,122 | $9.45 | $152.4K | 849,217 |
| Feb 25, 2025↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 14,168 | $9.45 | $133.9K | 117,901 |
| Feb 25, 2025↗ | SCANGOS GEORGE A | Director | Sell | 10,056 | $9.45 | $95.1K | 698,239 |
| Feb 19, 2025↗ | SCANGOS GEORGE A | Director | Sell | 10,964 | $9.81 | $107.6K | 708,295 |
| Jan 8, 2025↗ | SATO VICKI L | Director | Sell | 10,960 | $12.52 | $137.2K | 1,312,390 |
| Sep 10, 2024↗ | Napolitano Janet | Director | Sell | 12,190 | $7.80 | $95.0K | 11,616 |
| Jun 12, 2024↗ | Ramasastry Saira | Director | Sell | 4,000 | $10.95 | $43.8K | 14,619 |
| Apr 4, 2024↗ | De Backer Marianne | Chief Executive Officer | Sell | 72,995 | $9.46 | $690.4K | 678,457 |
| Apr 2, 2024↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 2,711 | $10.05 | $27.3K | 132,069 |
| Mar 28, 2024↗ | Lee Sung | EVP & Chief Financial Officer | Sell | 6,008 | $9.89 | $59.4K | 100,492 |
| Feb 26, 2024↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 12,296 | $10.05 | $123.5K | 134,780 |
| Feb 26, 2024↗ | Pang Phillip | EVP & Chief Medical Officer | Sell | 14,568 | $10.05 | $146.3K | 250,111 |
| Feb 26, 2024↗ | SCANGOS GEORGE A | Director | Sell | 27,750 | $11.07 | $307.3K | 130,711 |
| Feb 20, 2024↗ | SCANGOS GEORGE A | Director | Sell | 27,750 | $10.23 | $283.8K | 157,611 |
| Feb 16, 2024↗ | Pang Phillip | EVP & Chief Medical Officer | Sell | 3,321 | $10.24 | $34.0K | 264,679 |
| Jul 5, 2023↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 700 | $25.11 | $17.6K | 16,684,000 |
| Jul 3, 2023↗ | SATO VICKI L | Director | Sell | 18,000 | $24.66 | $443.9K | 1,315,350 |
| Jun 30, 2023↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 96,952 | $25.17 | $2.44M | 16,774,700 |
Showing 1–50 of 207
1 / 5
VIR Insider Buying Activity
The following table shows recent insider purchases of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.
No insider buying activity found for VIR in the last 12 months.
VIR Insider Selling Activity
The following table shows recent insider sales of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $9.51 | $209.2K | 1,122,590 |
| Feb 26, 2026↗ | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 14,762 | $9.53 | $140.7K | 1,020,700 |
| Feb 26, 2026↗ | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 3,505 | $9.69 | $34.0K | 155,913 |
| Feb 26, 2026↗ | SATO VICKI L | director | Sell | 42,377 | $9.75 | $413.4K | 1,144,590 |
| Feb 24, 2026↗ | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 38,078 | $7.45 | $283.8K | 1,035,470 |
| Feb 24, 2026↗ | de Verneuil Vanina | General Counsel | Sell | 4,445 | $7.45 | $33.1K | 129,799 |
| Feb 24, 2026↗ | Eisner Mark | VP | Sell | 4,178 | $7.45 | $31.1K | 157,529 |
| Feb 24, 2026↗ | O'Byrne Jason | CFO | Sell | 2,089 | $7.45 | $15.6K | 164,249 |
| Feb 24, 2026↗ | Sabatini Brent | Principal Accounting Officer | Sell | 1,829 | $7.45 | $13.6K | 71,043 |
| Feb 18, 2026↗ | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 1,530 | $7.79 | $11.9K | 0 |
| Feb 3, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $7.71 | $169.7K | 1,144,390 |
| Jan 5, 2026↗ | SATO VICKI L | director | Sell | 22,000 | $5.93 | $130.4K | 1,166,390 |
| Dec 3, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 191,854 | $5.98 | $1.15M | 13,728,900 |
| Dec 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $6.00 | $132.1K | 1,188,390 |
| Dec 1, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 189,431 | $6.41 | $1.21M | 13,982,300 |
| Nov 26, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 463,774 | $6.27 | $2.91M | 14,346,200 |
| Nov 4, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.64 | $124.0K | 1,210,390 |
| Oct 30, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 24,553 | $6.50 | $159.7K | 14,574,100 |
| Oct 28, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 113,099 | $6.01 | $679.9K | 14,664,900 |
| Oct 24, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 298,649 | $6.07 | $1.81M | 14,866,000 |
| Oct 22, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 330,210 | $6.23 | $2.06M | 15,120,000 |
| Oct 17, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 29,515 | $6.08 | $179.6K | 15,353,300 |
| Oct 14, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 251,360 | $6.14 | $1.54M | 15,372,300 |
| Oct 9, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 538,375 | $5.99 | $3.22M | 16,087,600 |
| Oct 7, 2025↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 524,297 | $5.57 | $2.92M | 16,233,700 |
| Oct 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.84 | $128.4K | 1,232,390 |
| Sep 3, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.8K | 1,254,390 |
| Aug 4, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.7K | 1,276,390 |
| Jul 17, 2025↗ | Eisner Mark | EVP and Chief Medical Officer | Sell | 10,382 | $5.47 | $56.8K | 108,204 |
| Jul 2, 2025↗ | SATO VICKI L | Director | Sell | 22,000 | $5.10 | $112.2K | 1,298,390 |
| Jun 2, 2025↗ | Napolitano Janet | Director | Sell | 3,200 | $5.05 | $16.1K | 16,416 |
| Apr 4, 2025↗ | De Backer Marianne | Chief Executive Officer | Sell | 79,712 | $5.95 | $474.2K | 769,505 |
| Feb 25, 2025↗ | De Backer Marianne | Chief Executive Officer | Sell | 16,122 | $9.45 | $152.4K | 849,217 |
| Feb 25, 2025↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 14,168 | $9.45 | $133.9K | 117,901 |
| Feb 25, 2025↗ | SCANGOS GEORGE A | Director | Sell | 10,056 | $9.45 | $95.1K | 698,239 |
| Feb 19, 2025↗ | SCANGOS GEORGE A | Director | Sell | 10,964 | $9.81 | $107.6K | 708,295 |
| Jan 8, 2025↗ | SATO VICKI L | Director | Sell | 10,960 | $12.52 | $137.2K | 1,312,390 |
| Sep 10, 2024↗ | Napolitano Janet | Director | Sell | 12,190 | $7.80 | $95.0K | 11,616 |
| Jun 12, 2024↗ | Ramasastry Saira | Director | Sell | 4,000 | $10.95 | $43.8K | 14,619 |
| Apr 4, 2024↗ | De Backer Marianne | Chief Executive Officer | Sell | 72,995 | $9.46 | $690.4K | 678,457 |
| Apr 2, 2024↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 2,711 | $10.05 | $27.3K | 132,069 |
| Mar 28, 2024↗ | Lee Sung | EVP & Chief Financial Officer | Sell | 6,008 | $9.89 | $59.4K | 100,492 |
| Feb 26, 2024↗ | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 12,296 | $10.05 | $123.5K | 134,780 |
| Feb 26, 2024↗ | Pang Phillip | EVP & Chief Medical Officer | Sell | 14,568 | $10.05 | $146.3K | 250,111 |
| Feb 26, 2024↗ | SCANGOS GEORGE A | Director | Sell | 27,750 | $11.07 | $307.3K | 130,711 |
| Feb 20, 2024↗ | SCANGOS GEORGE A | Director | Sell | 27,750 | $10.23 | $283.8K | 157,611 |
| Feb 16, 2024↗ | Pang Phillip | EVP & Chief Medical Officer | Sell | 3,321 | $10.24 | $34.0K | 264,679 |
| Jul 5, 2023↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 700 | $25.11 | $17.6K | 16,684,000 |
| Jul 3, 2023↗ | SATO VICKI L | Director | Sell | 18,000 | $24.66 | $443.9K | 1,315,350 |
| Jun 30, 2023↗ | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 96,952 | $25.17 | $2.44M | 16,774,700 |
VIR Insiders
Similar Stocks to VIR
VRTX
Vertex Pharmaceuticals Incorporated
$452.29-2.20%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$745.34-1.66%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$317.24-0.96%
$42.07B
INSM
Insmed Incorporated
$143.85-0.06%
$30.07B
UTHR
United Therapeutics Corporation
$531.23-1.63%
$23.50B
MRNA
Moderna, Inc.
$52.27-3.15%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.86-1.55%
$20.08B
RPRX
Royalty Pharma plc
$45.94-0.36%
$19.56B